A novel combinatorial strategy using Seliciclib® and Belinostat® for eradication of non-small cell lung cancer via apoptosis induction and BID activation

Journal Article
Publication Work Type: 
Research Paper
Magazine \ Newspaper: 
Cancer Letters
Volume Number: 
381
Pages: 
49-57